Mrs. Ortez has type III breast cancer and is now concluding the trial portion of a certain research study about this condition. She has responding well to the series of neoplastic medications and is currently in remmision. The researchers and her surgeon have informed both mrs Ortez and her husband that there is the possibility that her unique type of cancer could have a genetic foundation. Most at risk would be her 8 year old daughter, through both her 10 yr old and 2 yr old sons could carry the genetic mutation for this cancer. How do you, as her primary nurses, address her concerns for possible genetic testing of her children? Should the identification of the children's risk as possible carriers of this specific gene be identified at this time? Should the testing be even considered to be done at this time?
Mrs. Ortez has type III breast cancer and is now concluding the trial portion of a certain research study about this condition. She has responding well to the series of neoplastic medications and is currently in remmision. The researchers and her surgeon have informed both mrs Ortez and her husband that there is the possibility that her unique type of cancer could have a genetic foundation. Most at risk would be her 8 year old daughter, through both her 10 yr old and 2 yr old sons could carry the genetic mutation for this cancer. How do you, as her primary nurses, address her concerns for possible genetic testing of her children? Should the identification of the children's risk as possible carriers of this specific gene be identified at this time? Should the testing be even considered to be done at this time?
Stage III breast cancer is a stage where the cancer has spread beyonf the tumor region and might have invaded the muscles and the lymph nodes but not to distant organs.
Step by step
Solved in 4 steps
